首页> 美国卫生研究院文献>Substance Abuse Treatment Prevention and Policy >Higher doses of naloxone are needed in the synthetic opiod era
【2h】

Higher doses of naloxone are needed in the synthetic opiod era

机译:合成阿片类药物时代需要更高剂量的纳洛酮

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There has been a dramatic increase of deaths due to illicit fentanyl. We examined the pharmacology of fentanyl and reviewed data on the number of repeat doses of naloxone used to treat fentanyl overdoses. Multiple sequential doses of naloxone have been required in a certain percentage of opioid overdoses due to fentanyl. In addition, fentanyl appears to differ from other opioids as having a very rapid onset with high systemic levels found in overdose victims. A rapid competition is required by naloxone to out-compete large numbers of opioid receptors occupied by fentanyl in the CNS. Taken together, we propose that higher doses of naloxone are needed to combat the new era of overdoses due to the more potent synthetic opioids such as fentanyl.
机译:非法芬太尼致死的人数急剧增加。我们检查了芬太尼的药理作用,并复查了用于治疗芬太尼过量的纳洛酮重复给药次数的数据。由于芬太尼,一定比例的阿片类药物过量需要纳洛酮多次给药。此外,芬太尼似乎与其他阿片类药物不同,因为在过量用药中起病速度非常快,全身水平很高。纳洛酮需要快速竞争,才能与中枢神经系统中芬太尼所占据的大量阿片受体竞争。两者合计,我们认为,由于更有效的合成阿片类药物(如芬太尼),需要更高剂量的纳洛酮来应对药物过量的新时代。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号